PARP inhibition causes replication stress in preclinical models of high risk neuroblastoma and synergises with inhibition of ATR

被引：0
|
作者：
Southgate, Harriet [1 ]
Curtin, Nicola J. [1 ]
Tweddle, Deborah A. [1 ]
机构：
[1] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF CANCER | 2019年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
57
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [31] Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models
    Dunlop, Charles R.
    Wallez, Yann
    Johnson, Timothy Isaac
    Fernandez, Sandra Bernaldo de Quiros
    Durant, Stephen T.
    Cadogan, Elaine B.
    Lau, Alan
    Richards, Frances M.
    Jodrell, Duncan, I
    BRITISH JOURNAL OF CANCER, 2020, 123 (09) : 1424 - 1436
  • [32] Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer models
    Charles R. Dunlop
    Yann Wallez
    Timothy Isaac Johnson
    Sandra Bernaldo de Quirós Fernández
    Stephen T. Durant
    Elaine B. Cadogan
    Alan Lau
    Frances M. Richards
    Duncan I. Jodrell
    British Journal of Cancer, 2020, 123 : 1424 - 1436
  • [33] ATR Inhibition and Replication Stress Converge on a BCL6-Mediated Reversal of the Dark Zone Signature in DLBCL
    Chan, Allison
    Anbuselvan, Akshaya
    Jaynes, Patrick
    Prabhu, Nayana
    Ju, Yuan
    Lee, Jane Jia Hui
    Tan, Tze King
    Goh, Jasmine
    Foiani, Marco
    Sanda, Takaomi
    Tam, Wai Leong
    O'Connor, Mark J.
    Chow, Edward K.
    Jeyasekharan, Anand Devaprasath D.
    BLOOD, 2024, 144 : 2782 - 2783
  • [34] GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition for through Increased DNA Damage and Enhanced Replication Stress
    Mullen, Mary M.
    Lomonosova, Elena
    Toboni, Michael D.
    Oplt, Alyssa
    Cybulla, Emily
    Blachut, Barbara
    Zhao, Peinan
    Noia, Hollie
    Wilke, Daniel
    Rankin, Erinn B.
    Kuroki, Lindsay M.
    Hagemann, Andrea R.
    Hagemann, Ian S.
    McCourt, Carolyn K.
    Thaker, Premal H.
    Mutch, David G.
    Powell, Matthew A.
    Mosammaparast, Nima
    Vindigni, Alessandro
    Fuh, Katherine C.
    MOLECULAR CANCER RESEARCH, 2022, 20 (02) : 265 - 279
  • [35] Chemical Inhibition of the Replication Stress Response Causes DNA Damage and Delayed Regeneration in <it>S</it>. <it>mediterranea</it>
    Lillian Nguyen
    Ishaq, Ariana
    Sheppard, Taylor
    Velasquez, Elizabeth
    Ahmed, Youssef
    Montes, Patricia
    Arroyo, Jimena
    Sawyer, Nathaniel
    Tirgar, Reyhaneh
    Shamoon, Ushna
    Akpati, Lois
    Nam, Edward
    FASEB JOURNAL, 2020, 34
  • [36] Radiotherapy plus Inhibition of the proximal DNA Damage Repair Kinases ATM and ATR in preclinical Soft Tissue Sarcoma Models
    Anders, Heike
    Velezmoro, Laura
    Orth, Michael
    Maas, Jessica
    Gehr, Katharina
    Brix, Nikko
    Hennel, Roman
    Belka, Claus
    Unger, Kristian
    Lauber, Kirsten
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S55 - S55
  • [37] The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models
    O'Connor, Lenka Oplustil
    Rulten, Stuart L.
    Cranston, Aaron N.
    Odedra, Rajesh
    Brown, Henry
    Jaspers, Janneke E.
    Jones, Louise
    Knights, Charlotte
    Evers, Bastiaan
    Ting, Attilla
    Bradbury, Robert H.
    Pajic, Marina
    Rottenberg, Sven
    Jonkers, Jos
    Rudge, David
    Martin, Niall M. B.
    Caldecott, Keith W.
    Lau, Alan
    O'Connor, Mark J.
    CANCER RESEARCH, 2016, 76 (20) : 6084 - 6094
  • [38] Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program
    Smith, Malcolm A.
    Reynolds, C. Patrick
    Kang, Min H.
    Kolb, E. Anders
    Gorlick, Richard
    Carol, Hernan
    Lock, Richard B.
    Keir, Stephen T.
    Maris, John M.
    Billups, Catherine A.
    Lyalin, Dmitry
    Kurmasheva, Raushan T.
    Houghton, Peter J.
    CLINICAL CANCER RESEARCH, 2015, 21 (04) : 819 - 832
  • [39] Disconnect between COX-2 selective inhibition and cardiovascular risk in preclinical models
    Koshman, Yevgeniya E.
    Bielinski, Aimee L.
    Bird, Brandan M.
    Green, Jonathon R.
    Kowalkowski, Kenneth L.
    Jie Lai-Zhang
    Mahalingaiah, Prathap Kumar S.
    Sawicki, James W.
    Talaty, Nari N.
    Wilsey, Amanda W.
    Zafiratos, Mark T.
    Van Vleet, Terry R.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 123
  • [40] Disconnect between COX-2 selective inhibition and cardiovascular risk in preclinical models
    Koshman, Yevgeniya E.
    Bielinski, Aimee L.
    Bird, Brandan M.
    Green, Jonathon R.
    Kowalkowski, Kenneth L.
    Lai-Zhang, Jie
    Mahalingaiah, Prathap Kumar
    Sawicki, James W.
    Talaty, Nari N.
    Wilsey, Amanda S.
    Zafiratos, Mark T.
    Van Vleet, Terry R.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 120
12345